Unresectable Chemorefractory Liver Metastases: Radioembolization with90Y Microspheres—Safety, Efficacy, and Survival
Authors:
- Robert J. LewandowskiRLRobert J. Lewandowski
- Mary F. MulcahyMMMary F. Mulcahy
- Bassel AtassiBABassel Atassi
- Robert K. RyuRRRobert K. Ryu
- Vanessa L. GatesVGVanessa L. Gates
- Albert A. NemcekANAlbert A. Nemcek
- Omar BarakatOBOmar Barakat
- Al BensonABAl Benson
- Robert MandalRMRobert Mandal
- Mark TalamontiMTMark Talamonti
- Ching-Yee O. WongCWChing-Yee O. Wong
- 1 May 2008
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 247 (2) , 507-515
Abstract
Purpose: To prospectively evaluate the safety, efficacy, and survival of patients with chemorefractory liver metastases who have been treated with yttrium 90 (90Y) glass microspheres. Materials and Methods: Institutional review boards from two institutions approved the HIPAA-compliant study; all patients provided informed consent. One hundred thirty-seven patients underwent 225 administrations of 90Y microspheres by using intraarterial infusion. Primary sites (origins) included colon, breast, neuroendocrine, pancreas, lung, cholangiocarcinoma, melanoma, renal, esophageal, ovary, adenocarcinoma of unknown primary, lymphoma, gastric, duodenal, bladder, angiosarcoma, squamous cell carcinoma, thyroid, adrenal, and parotid. Patients underwent evaluation of baseline and follow-up liver function and tumor markers and computed tomographic or magnetic resonance imaging. Patients were observed for survival from first treatment. Median survival (in days) and corresponding 95% confidence intervals were computed by us...Keywords
This publication has 27 references indexed in Scilit:
- Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantationJournal of Surgical Oncology, 2006
- Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver MalignanciesJournal of Vascular and Interventional Radiology, 2006
- The Role of Liver Resections for Noncolorectal, Nonneuroendocrine Metastases: Experience With 142 Observed CasesAnnals of Surgical Oncology, 2005
- Partial Hepatectomy for Metastases From Noncolorectal, Nonneuroendocrine CarcinomaAnnals of Surgery, 2005
- Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysisLiver Transplantation, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM‐90 MICROSPHERESAnz Journal of Surgery, 1992
- Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rateJournal of Surgical Oncology, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958